Creative Biolabs provides an AI-Powered Spatial Transcriptomics Service for Solid Tumors to address key challenges in immunotherapy development, including mapping cold-to-hot tumor transitions, quantifying T-cell exhaustion in situ, and understanding limited tumor core penetration of therapeutic cells. This service enables high-resolution characterization of the tumor microenvironment through spatial transcriptomic profiling and deep learning–based cellular neighborhood analysis. By revealing spatially resolved immune–tumor interactions, Creative Biolabs supports optimized T-cell infiltration strategies and accelerates the development of more effective, precision-guided immunotherapies.
Spatial transcriptomics enables gene expression profiling within intact tissue architecture, revealing how immune cells are distributed across tumor regions. Recent studies demonstrate that T cells often accumulate at tumor margins rather than penetrating the core due to stromal barriers and immunosuppressive signals. Integrating AI enhances pattern recognition and predictive modeling, allowing deeper insight into T-cell dysfunction and spatial immune evasion mechanisms in solid tumors.
Creative Biolabs provides a transformative lens through which to view solid tumor biology. By integrating whole-transcriptome spatial sequencing with advanced AI, we help you move beyond traditional bulk RNA-seq and flow cytometry, which lose the critical geography of the tumor. We specifically address the T-cell exclusion problem by mapping the physical and molecular barriers at the leading edge and tumor core.
Our key capabilities include high-resolution spatial mapping of T cells within the tumor core versus stroma. We identify immune-suppressive niches and physical barriers, such as stromal regions. We offer AI-based classification of tumor immune phenotypes, including inflamed, excluded, and desert phenotypes. We conduct ligand receptor interaction analysis to reveal cell-cell communication networks. Furthermore, we provide predictive insights for immunotherapy response and target discovery.
Discover How We Can Help - Request a Consultation.
| Advanced Spatial Profiling Platforms | Multi-Modal Integration |
|
|
| AI-Driven Analytical Modules | Custom Study Design |
|
|
Required Starting Materials: Clients typically provide Formalin-Fixed Paraffin-Embedded tissue blocks or fresh-frozen tissue sections, along with relevant clinical metadata or specific markers of interest to guide AI training models.
Final Deliverables: You will receive Interactive Spatial Expression Maps showing T-cell distribution relative to tumor boundaries, A Comprehensive Bioinformatics Report including pathway enrichment within the tumor core, and AI-quantified T-cell infiltration metrics.
Q: How does AI improve the spatial transcriptomics analysis?
A: Our AI models automate cell segmentation and identify complex neighborhoods that the human eye might miss, such as specific clusters of immunosuppressive cells surrounding T-cells.
Q: Can you work with degraded FFPE samples?
A: Yes, we have optimized protocols for FFPE tissue. We conduct strict quality checks to ensure the RNA is sufficient for meaningful spatial mapping.
Q: How do you handle the massive data sets generated by these projects?
A: Our bioinformatics team provides a curated, easy-to-navigate report. We also offer raw data files and specialized software tools for your internal review.
Q: Can this service be customized for rare solid tumors?
A: We specialize in custom-tailored projects and can adapt our AI training sets to accommodate unique histological features of rare tumor types.
Creative Biolabs uses AI to analyze longitudinal clinical and molecular data, enabling dynamic monitoring of treatment responses, resistance mechanisms, and disease progression to support data-driven optimization of CAR/TCR immunotherapies.
Learn More →Creative Biolabs provides AI-guided solutions for universal CAR-T development, optimizing gene editing strategies, immune compatibility, and persistence to support scalable, off-the-shelf cell therapies with improved safety and efficacy.
Learn More →Creative Biolabs' AI-Powered Spatial Transcriptomics Service is the definitive solution for researchers seeking to master the complexities of T-cell infiltration in solid tumors. By integrating high-resolution spatial profiling with advanced artificial intelligence, we enable deep insights into tumor immune microenvironments, helping you accelerate the development of more precise and effective immunotherapies. Reach out to our expert team today to learn more and explore tailored solutions for your research project.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION